BONE CANCER, CHORDOMA & LIMB SALVAGE

Advanced Bone Cancer Care in China

Bone cancers, chordomas, and soft tissue sarcomas are rare and complex tumors that often resist standard radiation and chemotherapy. China provides world-leading expertise in two crucial areas: curative heavy carbon ion radiation for tough tumors of the spine and pelvis, and custom 3D-printed titanium implants that save limbs and avoid amputation in over 95% of surgical cases.

PARTICLE BEAMS, 3D SURGERY & TARGETED MEDICINE

Key Bone Cancer Treatments in China

Carbon ion particle radiation, custom 3D-printed titanium prostheses, and targeted anti-angiogenic therapies.

Carbon Ion Heavy Radiation

Intense heavy particle beams that destroy radioresistant bone tumors and chordomas while stopping safely before delicate spinal nerves and pelvic organs.

3D-Printed Limb-Saving Surgery

Custom titanium prostheses crafted to fit your exact bone structure, successfully preserving the limb and restoring movement without amputation.

Targeted Cell Therapies (TCR-T)

Access to cutting-edge engineered T-cell therapies (targeting NY-ESO-1 and MAGE-A4) for difficult advanced synovial and soft tissue sarcomas.

WHY CHOOSE US

Why Choose China Cancer Help for Bone Cancer Care

A specialized clinical continuum connecting international sarcoma and chordoma patients directly with China’s premier orthopedic oncology centers.

China offers unmatched clinical advantages in complex bone oncology and radioresistant sarcomas. For challenging tumors of the spine, sacrum, and pelvis—such as chordomas—China operates two of the world’s most experienced carbon ion radiotherapy centers, delivering curative radiation doses while safeguarding the spinal cord and pelvic organs.

For surgical cases, Chinese surgeons lead the world in custom 3D-printed titanium implants, routinely achieving limb salvage in complex anatomical areas that previously required amputation. Every patient is supported by a dedicated orthopedic oncology team with transparent public hospital pricing.

CASE EVALUATION PATHWAY

A Structured Pathway from Records to Care

A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.

01. Submit Records Online

Upload pathology reports, biomarker NGS profiles, and imaging scans through our confidential clinical intake portal.

02. Remote MDT Review

National Clinical Research Center oncology boards evaluate eligibility, target expression, and formulate a customized protocol.

03. Visa & Admission

Receive official hospital medical invitation letters, transparent pricing schedules, and expedited department admission.

04. Treatment & Follow-up

Inpatient cellular or particle therapy in ISO-GMP cleanrooms with dedicated bilingual escorts and remote post-discharge care.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international Bone Cancer patients considering advanced treatment in China.

Surgeons design custom porous titanium implants based on high-resolution 3D bone CT scans. The trabecular structure encourages your own bone to grow into the implant, creating permanent structural stability and saving the limb.
Yes. Carbon ion radiotherapy is the international gold standard for radioresistant chordomas and chondrosarcomas, achieving high local tumor control without damaging the spinal cord or bowel.
Patients have access to approved multi-target tyrosine kinase inhibitors such as Anlotinib and Apatinib, as well as novel TCR-T cellular trials for specific antigen targets like NY-ESO-1.
Your MRI/CT scans, biopsy pathology, and surgical history are reviewed by senior orthopedic oncology surgeons and radiation physicists within 48 hours.

MUSCULOSKELETAL ONCOLOGY CLINICAL ASSESSMENT

Request a Confidential Case Review for Bone Cancer

Share your MRI/CT scans, biopsy slides, and previous surgical records for an expert evaluation by our senior bone oncology team.

    Bone Cancer